Keyword: Novartis

News

Novartis Acquires Morphosys for €2.7 Billion in Cash

06.02.2024 -

Novartis recently announced its agreement to acquire Morphosys AG, a Germany-based biopharmaceutical company specializing in oncology medicines. This strategic move...

News

Isomorphic Labs to Collaborate with Eli Lilly and Novartis

10.01.2024 -

Isomorphic Labs announced strategic collaborations with leading pharmaceutical companies, Eli Lilly and Company and Novartis. These partnerships have the potential to be...

News

Sandoz Spin-off from Novartis to Start on October 4, 2023

25.09.2023 -

Novartis today confirmed the plan to spin off 100% of its generic drugs arm Sandoz, with trading of the new company’s shares as well as ADRs (American Depositary Receipts...

News

Novartis Completes Acquisition of Chinook Therapeutics

14.08.2023 -

Novartis has completed its acquisition of US biopharma Chinook Therapeutics. The acquisition, which was announced in June, has a value of up to $3.5 billion.

News

Novartis Divests Ophthalmology Assets to Bausch + Lomb for Up to $2.5 Billion

03.07.2023 -

Novartis has signed an agreement to divest its 'front of eye' ophthalmology assets to Bausch + Lomb, a global eye health company. The transaction is valued at up to $2.5...

News

Novartis Takes Chinook Therapeutics for $3.5 billion

15.06.2023 -

Novartis has agreed to acquire US biopharma Chinook Therapeutics for $3.5 billion. Chinook has two late-stage drugs in development – Atrasentan and Zigakibart – to treat...

News

Sandoz in Biosimilars Pact with Just – Evotec Biologics

12.05.2023 -

As Novartis moves toward shedding generics subsidiary Sandoz, which it touts as a global leader in off-patent generic and biosimilar drugs, Sandoz has agreed a multi-year...

News

Sangamo Reviews Options as Drugmakers Terminate Deals

22.03.2023 -

US biotech Sangamo Therapeutics is studying alternative options to advance its neurological disease programs after both Novartis and Biogen ended their respective...